Xiaoxun Zhang

Chongqing, 400038, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

MANF attenuates cholestatic liver injury by enhancing GRP78-PERK interaction.

MANF attenuates cholestatic liver injury by enhancing GRP78-PERK interaction.

Journal: Biochemical pharmacology

Published: August 20, 2026

Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD.

Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD.

Journal: Nature communications

Published: June 20, 2025

The SEMA7AN559Y mutation facilitates the development of metabolic dysfunction-associated steatotic liver disease by inducing ROS/NLRP3-mediated hepatic cell pyroptosis.

The SEMA7AN559Y mutation facilitates the development of metabolic dysfunction-associated steatotic liver disease by inducing ROS/NLRP3-mediated hepatic cell pyroptosis.

Journal: Metabolism: clinical and experimental

Published: May 30, 2025

Tumor necrosis factor alpha-induced activation of SREBP2 promotes cholesterol biosynthesis in cholestasis.

Tumor necrosis factor alpha-induced activation of SREBP2 promotes cholesterol biosynthesis in cholestasis.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: February 27, 2025

Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome.

Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome.

Journal: Journal of cellular and molecular medicine

Published: February 06, 2025

Aluminum adjuvant promotes liver inflammation and fibrosis in mice: A novel approach to establish a liver fibrosis animal model.

Aluminum adjuvant promotes liver inflammation and fibrosis in mice: A novel approach to establish a liver fibrosis animal model.

Journal: Liver research (Beijing, China)

Published: January 27, 2025

Conjugated bile acid-driven CD14+CD16+ monocyte infiltration promotes cholestatic liver injury by enhancing hepatocyte necroptosis.

Conjugated bile acid-driven CD14+CD16+ monocyte infiltration promotes cholestatic liver injury by enhancing hepatocyte necroptosis.

Journal: JHEP reports : innovation in hepatology

Published: December 01, 2024

Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population.

Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population.

Journal: Science translational medicine

Published: November 06, 2024

Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease.

Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease.

Journal: Nature genetics

Published: July 27, 2024

Deficiency of myeloid NPC1 exacerbates liver injury and fibrosis by impairing macrophage efferocytosis.

Deficiency of myeloid NPC1 exacerbates liver injury and fibrosis by impairing macrophage efferocytosis.

Journal: Journal of advanced research

Published: July 16, 2024

STING-mediated IL-6 Inhibits OATP1B1 Expression via the TCF4 Signaling Pathway in Cholestasis.

STING-mediated IL-6 Inhibits OATP1B1 Expression via the TCF4 Signaling Pathway in Cholestasis.

Journal: Journal of clinical and translational hepatology

Published: January 12, 2024

Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation.

Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation.

Journal: Hepatology (Baltimore, Md.)

Published: January 12, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026